Back to News
Market Impact: 0.15

Most Medicare Beneficiaries Will Lose This Popular Benefit on Jan. 31. Here's What Seniors Need to Know.

NDAQ
Healthcare & BiotechRegulation & LegislationPandemic & Health EventsFiscal Policy & BudgetTechnology & Innovation
Most Medicare Beneficiaries Will Lose This Popular Benefit on Jan. 31. Here's What Seniors Need to Know.

Medicare's pandemic-era telehealth flexibilities are set to expire on Jan. 31, reversing much of the at-home virtual care expansion that grew telehealth use from roughly 10% of beneficiaries in 2020 to about 25% (nearly 6.8 million) in 2025. Post-deadline, rural patients retain limited facility-based telehealth, urban/suburban beneficiaries lose most routine at-home telehealth, several therapy provider types (PT, OT, speech-language, audiology) will no longer bill Medicare for telehealth, and behavioral health and a few specific services remain authorized; Congress is considering a stalled extension through 2027, creating near-term policy uncertainty and downside revenue/access risk for telehealth providers and related healthcare technology players.

Analysis

Market structure: The Jan. 31 rollback removes at-home access for roughly 25% of Medicare users (~6.8M seniors), shifting demand back to brick‑and‑mortar providers and Medicare Advantage-managed care. Winners in the near term are hospitals, outpatient clinics and MA carriers (UNH, HUM) that capture increased visit volume and associated ancillary revenue; losers are pure-play telehealth platforms (TDOC, AMWL) and ancillary tele‑therapy providers that lose billing access and pricing power. Expect price pressure and lower utilization multiples for exposed telehealth names over the next 30–90 days unless Congress intervenes. Risk assessment: The primary tail risk is a last‑minute Congressional extension (through 2027) that would re‑rate telehealth equities upward within 48–72 hours; counterparty risk includes MA plans independently maintaining coverage which mutes downside. Immediate window: Jan 31 legislative outcome drives >10–30% swing potential in small/mid telehealth caps; short term (1–3 months) execution risk around patient rebooking and provider contracts; long term (2–5 years) secular telehealth adoption remains intact but likely concentrated in behavioral health and employer/MA channels. Hidden dependencies: state parity laws, MA carve‑outs, and provider billing shifts (e.g., tele‑mental health growth) will determine realized revenue loss. Trade implications: Direct short bias on pure telehealth (TDOC, AMWL) into Jan 31 with protective hedges; long selective payors (UNH, HUM) and acute care operators (HCA) to capture higher in‑person volume and pricing. Options: implement short‑dated put spreads on TDOC/AMWL expiring Feb–Mar 2025 sized 1–2% portfolio notional to capture 15–30% downside, financed by selling further OTM puts; consider long calls on UNH (3–6 month expiries) to express upside if utilization and MA pricing improve. Entry: initiate within 7–30 days; exit within 48–72 hours if Congress passes a multi‑year extension or if MA plans publicly commit to maintained telehealth coverage. Contrarian angles: Consensus assumes permanent damage to telehealth multiples; that may be overdone because behavioral health remains covered (structural revenue floor) and MA plans could opportunistically expand benefits to retain members — insulating larger telehealth vendors. Historical parallels: prior temporary CMS flexibilities have been repeatedly extended, so a political reversion is a realistic 30–50% probability before Jan 31; if extension passes, small telehealth caps may gap >30% intraday. Unintended consequence: forced in‑person visits could accelerate MA enrollment and shift reimbursement mix, benefiting vertically integrated insurers and providers while compressing standalone telehealth valuation multiples.